Form 4: Certara Executive Equity Compensation Update

Certara President and Chief Commercial Officer Leif E. Pedersen received new performance and restricted stock unit grants.

Summary

• Leif E. Pedersen, President and Chief Commercial Officer of Certara, Inc., engaged in a series of equity-based transactions on May 11, 2026.
• The reporting person disposed of 68,348 performance stock units (PSUs) and simultaneously acquired 68,348 new PSUs.
• Additionally, the reporting person was granted 74,074 restricted stock units (RSUs) and 111,111 new PSUs.
• These grants are part of the company's 2026 Long-Term Incentive Plan and are subject to performance-based vesting criteria.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation that does not signal a change in company strategy or financial health.

Positives

• Alignment of executive compensation with long-term shareholder value through performance-based equity grants.
• Retention of key leadership personnel through multi-year vesting schedules for RSUs and PSUs.

Negatives

• Potential for future share dilution upon the vesting and settlement of these equity units.

Risks

• Vesting of PSUs is contingent upon meeting specific total shareholder return thresholds, which may not be achieved.
• Market volatility could impact the ultimate value realized by the executive from these equity grants.

Future Outlook

The executive's compensation is tied to the company's total shareholder return performance through March 31, 2029, incentivizing long-term growth.

Management Comments

• The grants were approved by the Compensation Committee of the Board of Directors under the 2020 Incentive Plan.

Industry Context

StockSavvy.ai notes that this filing reflects standard executive compensation practices within the biopharmaceutical software and services sector, where long-term equity incentives are used to retain talent and align management with shareholder interests.

Comparison to Industry Standards

• The use of PSUs tied to total shareholder return is consistent with compensation structures at peer companies like Veeva Systems and Simulations Plus.
• Three-year vesting schedules for RSUs are standard practice for executive retention in the technology and life sciences industries.

Stakeholder Impact

• Shareholders should note the potential for future dilution as these units vest into common stock.

Next Steps

• Vesting of RSU installments on April 1, 2027, 2028, and 2029.
• Evaluation of performance criteria for PSU settlement through March 31, 2029.

Key Dates

Keywords

Certara, CERT, Executive Compensation, Form 4, Equity Grants, Insider Trading, Stock Units